2',3,4-Trifluoro-4'''-propyl-1,1':4',1'':4'',1'''-quaterphenyl, 95%, 1g

3,4-dihydropyrimidine-4-thione, 97%, 100mg

(S)-2-((tert-butoxycarbonyl)amino)-2-(3-fluorophenyl)acetic acid, 98%, 5g

Benactyzine Hydrochloride>98.0%(HPLC)(T)5g

(4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)DIHYDROFURAN-2(3H)-ONE, 95.0%, 10g

2-(1H-1,2,4-Triazol-1-yl)ethanamine dihydrochloride, 95.0%, 1g

5-methylsalicylic acid, min. 98%, for synthesis, 5 g, plastic packaging.

3-(4-Isobutoxyphenyl)propanoic acid, 97%, 5g

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

D-Citrulline, 95.0%, 5g

3,5-Dithiocyanatopyridine-2,6-diamine, 95.0%, 1mg

3-Prop-2-ynyloxy-benzaldehyde, 95.0%, 5g

Methyl 2-((cyanomethyl)amino)benzoate, 97.0%, 250mg